FST and neuromuscular disease caused by qualitative or quantitative defects of dysferlin: The authors conclude that follistatin overexpression accelerated the degenerative features in the dysferlinopathy model, as the dystrophin-deficient mdx was not exacerbated [104], and suggest that muscle hypertrophy may have pernicious effects depending on the disease context.